Oral oncology, 2017-04, Vol.67, p.167-174
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis
- Ist Teil von
- Oral oncology, 2017-04, Vol.67, p.167-174
- Ort / Verlag
- England: Elsevier Ltd
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • Up to now, role of cetuximab for nasopharyngeal carcinoma (NPC) is unclear. • Distant metastasis is the main treatment failure pattern in NPC. • Adding cetuximab to chemoradiotherapy can improve distant metastasis-free survival. • Addition of cetuximab concurrent with first-line chemoradiotherapy is feasible.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1368-8375eISSN: 1879-0593DOI: 10.1016/j.oraloncology.2017.02.026Titel-ID: cdi_proquest_miscellaneous_1882082463
- Format
- –
- Schlagworte
- Adult, Antineoplastic Agents, Immunological - administration & dosage, Cetuximab, Cetuximab - administration & dosage, Chemoradiotherapy, Distant metastasis, Female, Hematology, Oncology and Palliative Medicine, Humans, Male, Nasopharyngeal carcinoma, Nasopharyngeal Neoplasms - therapy, Otolaryngology, Prognosis, Propensity score method, Prospective Studies, Survival Analysis